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ABSTRACT
The Activity of Alkaline Glutaraldehyde Against Bacterial Endospores and
Select Non-Enveloped Viruses
Justen Thalmus Despain
Department of Microbiology and Molecular Biology, BYU
Master of Science

Alkaline glutaraldehyde (GTA) has been used as a high level chemical disinfectant and
sterilant for many years and is known to kill a broad spectrum of organisms ranging from
vegetative eukaryotes to bacterial endospores. Although the mechanism of sporicidal action has
been studied on numerous occasions, GTA’s exact mechanism(s) of action are still debated.
In addition to the uncertainty of GTA’s mechanism(s) of action, GTA has also shown
significant variability in the time required to kill endospores and naked viruses. A better
knowledge of the lethal mechanism(s) of GTA is needed to understand this discrepancy in kill
times for GTA against spores of different species. Similar trends have been observed in GTA’s
activity against non-enveloped viruses.
Based on previous work, one proposed major mechanism of GTA’s sporicidal activity is
related to the number of available primary amines located on the surface of microbes. In this
study, we have compared the efficacy of GTA on spores from 5 Bacillus species. We have also
developed a method for staining these spores with amine reactive dyes to create fluorescent
profiles correlating to the abundance of free amino groups on each spore type. We also describe
a method for staining non-enveloped viruses to identify exposed primary amino groups on capsid
proteins that may act as targets for GTA, using amine reactive Gold nanoparticles.
We found that GTA 6-Log10 reduction times for various spore types varied at both the
batch and species level. Spore coat thickness and fluorescence were useful tools in predicting the
susceptibility of spores to GTA. Amine reactive gold particles (AuNPs) also proved useful in
identifying virus susceptibility to GTA. Ultimately, more reliable disinfection testing methods
are needed, and caution should be used when trying to extrapolate data generated from surrogate
organisms to other species.
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Introduction
Disinfection of surfaces and materials is a subject that has been studied extensively in an
effort to provide safe and effective inactivation of infectious organisms on everything from
children’s toys to precision surgical instruments. Yet, regardless of test standardization efforts
and optimal selection of surrogate test organisms, there is still a lot of variability seen in both the
time required to kill organisms, and the spectrum of organisms that are susceptible to a given
disinfectant. Bacterial endospores and non-enveloped (naked) viruses have received particular
attention, as their destruction is often the most difficult. Therefore, these agents are used in
testing disinfectants purposed to be used as sterilants for sensitive medical devices. These two
classes of microbes are also responsible for a number of clinically relevant diseases. This study
aims to bring better understanding to some of the factors involved in glutaraldehyde-based
disinfection testing. To begin, we will review what is known about bacterial endospores and
naked viruses and their mechanisms for resistance to chemical disinfectants. This will be
followed by an overview of some of the current methods and regulations for testing candidate
disinfectants and a review of one of the more well studied disinfectants, glutaraldehyde.
Bacterial Endospores
General Characteristics and Significance
Bacterial endospores (spores) are formed primarily by a small number of gram-positive
bacteria that are members of the Bacillus and Clostridium genera. Unlike spores from other
organisms such as fungi and protozoans, bacterial spores are not part of the replication cycle,
rather they are a defensive mechanism designed to allow bacteria to survive extreme conditions
that would otherwise destroy vegetative organisms. Spores are resistant to the lethal effects of
several classes of biocides, and can persist in extreme heat and dehydration conditions for
1

extended periods of time. Spores are virtually ametabolic, but can convert back into a vegetative
form upon sensing favorable environmental conditions (1-3). In the food and health industries,
spores are considered the most resistant type of microorganisms, and are used to validate
sterilization claims.
Sporulation and Development of Resistance
Sporulation is a process that is typically initiated as a result of nutrient starvation, though
other factors are also involved in starting this process (4). Some Clostridia species are known for
their ability to create organic solvents such as acetone during fermentation. This process is
known as solventogenesis and it has been linked to induction of sporulation in clostridia spores
(5). Divalent cations are generally added to media to produce high yields of resistant spores, as
they are required for normal sporogenesis (6). The primary molecular signals of sporogenesis are
still being defined. What is known, is that upregulation of histidine sensor kinase A moves
phosphate through a relay system that phosphorylates and activates SpoA, the master regulator
for initiating sporulation genes (1, 3, 7). Sporulation is a highly regulated process that once
begun, cannot be stopped (8, 9). Once properly formed, bacterial endospores become highly
resistant to heat, radiation, chemical disinfection, desiccation and mechanical destruction (10,
11)
At the onset of nutrient deprivation, the bacterial cell is split asymmetrically creating two
compartments designated the mother cell or sporangium and the forespore, both of which contain
a copy of the genome. The forespore is then engulfed by the mother cell creating a double lipid
membrane around the spore. At this point, the proteins required for the spore coat and cortex
peptidoglycan are formed in the mother cell and attached to the spore while the core begins to
replace water with calcium and dipicolinic acid. Next, the cell’s metabolism begins to shut down.
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Once the forespore has completed the coat and peptidoglycan layers, the mother cell will lyse
and release the fully formed spore (1, 4, 12, 13). Sporulation in Bacillus subtilis has been
thoroughly studied and used as a model for defining sporulation events in other spore-forming
bacteria (10, 14).
Spore Coat
There are three basic structures to
bacterial endospores; the coat, cortex
and core. Figure 1 shows an electron
micrograph of an endospore with its
various parts labeled. The coat is a
thick layer of protein responsible for
environmental fitness and in many cases,
resistance to external stresses such as
disinfection or extremes in temperature
or salinity (15). Its thickness and protein
composition can be modified by

Figure 1: A bacterial endospore. Exo – Exosporium;
Co – coat; Cx – Cortex

changing sporulation media (4). Removal of spore coats renders spores susceptible to treatment
with lysozyme, disinfectants and organic solvents (11, 16, 17). The spore coat has other
functions in addition to those listed above. For example, the coat acts like a molecular sieve that
can exclude large toxic molecules such as lysozyme but allow low molecular weight germinants
such as D-alanine, access to receptors at the cortex (4, 15, 17). Some spore species, such as
Bacillus anthracis, also have a loose fitting outer layer known as an exosporium in addition to
their coat, although its function is not fully understood (17). The coat of B. subtilis is made up of
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at least 70 different proteins (1) and makes up 78% of the protein weight of spores (18). Of these
proteins, there are some that regulate germination such as an alanine racemase enzyme, which
converts D-alanine to L-alanine. B. subtilis mutants for this protein have been observed to
germinate early while still encapsulated in the mother cell (19). CotA is a copper-dependent
laccase found in the coat of B subtilis, that contributes to UV and peroxide protection by creating
a pigment similar to melanin (20). The coat can also provide protection from phagocytosis by
immune cells as well as protection against predation by nematodes and other predators (21, 22).
Endospores generally have coats with two separate layers referred to as an inner and an outer
coat (15). Coat compositions can be quite diverse between species (1). Between the coat and
cortex is the outer membrane, the function of which is not well understood, though it is
implicated in aiding spore formation. Its removal has little effect on the resistance or survival of
the spore (23, 24).
Cortex
The cortex is composed of two distinct layers of peptidoglycan. The inner most layer is
called the germ cell wall and is composed of peptidoglycan similar to that of vegetative
organisms (25). The outer and thicker layer has the same general structure as normal
peptidoglycan with alternating N-acetyl-glucosamine (NAG) and N-acetyl-muramic acid (NAM)
and peptide side chains (26, 27), however, the outer layer contains muramic-δ-lactam and
significantly fewer peptides attached to NAM units. As a result, outer spore peptidoglycan is also
significantly less cross-linked than the germ cell peptidoglycan (26, 28). Between the cortex and
the core is a highly impermeable inner lipid membrane that repels even small nonpolar molecules
(29). The lipids found in the inner membrane have extremely low mobility, but they share
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structure similar to that of the vegetative organism’s membranes. What exactly causes this low
mobility is not known, though it likely contributes to spore resistance (24, 30).
Core
The core is severely dehydrated and is made up of ribosomes, DNA, dipicolinic acid
(DPA) and small acid-soluble proteins (SAPS). DPA makes up 5-15% of the spores dry weight
and is involved in resistance to UV radiation and in the desiccation process of the core during
sporulation (31). The replacement of water by DPA in the core is known to promote resistance to
wet heat, while SASP are thought to contribute to spore resistance to dry heat, further desiccation
and other forms of DNA damage (32, 33). SAPS make up 3-6 % of dry spore weight and saturate
dormant spore DNA. They also have been shown to alter the conformation of DNA from the B to
the A form, which contributes to UV resistance (33, 34).
Resistance to Biocides
In general, compounds that are bacteriostatic will also be sporostatic at similar
concentrations. However, sporicidal and bactericidal concentrations usually differ significantly
(35). Spores are resistant to several bactericidal agents, and therefore are often used as the
standard for testing label claims of high level disinfection and sterilization processes (36). Spore
are generally resistant to alcohols, quaternary ammonium compounds, many aldehydes, phenolic
compounds, and organic solvents (2, 37-39).
Bacillus anthracis
Bacillus are a genus of Gram positive spore-forming rods. B. anthracis is one of the
better known species in this genus. It has a number of unique biochemical properties that
distinguish it from the other Bacillus species (40). B. anthracis spores are best known for their
potential use as biological weapons due to their ability to cause pulmonary anthrax, a rapidly
5

progressing disease with a high mortality rate (41). These spores were mass produced as
bioweapons during the Cold War and the organism is currently on the Centers for Disease
Control’s list of Tier 1 select agents (42). As such, B. anthracis has received a significant amount
of interest and has been well studied. In addition to a protein coat, B. anthracis spores also have
a loose fitting exosporium composed of protein, lipid, and carbohydrates. However, this
exosporium has not been shown to contribute to either the spore’s protection or pathogenesis (43,
44). The spore coat of B. anthracis is thinner than that of B. subtilis, though in overall size, B.
anthracis is a mid-sized spore measuring about 1.5 µm in length. B. subtilis measures about 1.07
µm in length (10, 45).
Bacillus subtilis
B. subtilis is currently a model organism used to study general characteristics for most
Gram positive rods and forms one of the smallest of the bacillus spores (45). The molecular
mechanisms of sporulation have been heavily studied in B. subtilis such that most of what is
currently known about endospores in relation to sporulation, dormancy, resistance and
germination, has come as a result of studying B. subtilis (9, 14, 46). Its natural competency has
made it popular for use in molecular biology (47). It is also used industrially to produce some
enzymes and solvents (48). Compared to the other Bacillus species spores, B. subtilis has a very
thick coat (10, 49, 50). It does not have an exosporium, though some studies have reported a top
layer of the spore coat that is easily removed without removing the outer coat (4, 21, 51). B.
subtilis has also been used as a surrogate for B. anthracis in testing biocides (52, 53).
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Bacillus pumilus
B. pumilus spores are currently used in testing for the microbiocidal activity of UV light
and other radiation based sterilization methods (36, 54). One study performed by NASA
included a strain of B. pumilus that was more resistant to UV than any other Bacillus species ever
reported (55). It has also been employed as an agricultural fungicide (56). B. pumilus has a
thinner coat than B. subtilis which also is comprised of relatively few coat proteins, compared to
other Bacillus species spores (50, 57). It is not known to cause disease in humans and is
primarily used as a bioindicator for radiation sterilization.
Bacillus atrophaeus
B. atrophaeus, formerly B. globigii, is a Gram positive black or orange pigmented bacilli
that is closely related to B. subtilis. The pigmentation is retained during sporulation and is
thought to aid in resistance to UV radiation (58). It has been employed as a surrogate for B.
anthracis in testing biocides and decontamination procedures of spores (59). It is currently used
as a bio indicator to test dry heat and ethylene oxide sterilization methods (36). B. atrophaeus
spores are similar in size to B. anthracis spores (45). It also is not known to cause disease in
humans.
Geobacillus stearothermophilus
Formerly Bacillus stearothermophilus, G. stearothermophilus is a thermophilic bacterium
first isolated in 1920 from canned corn (60). G. stearothermophilus can be found in hot springs
as well as in soil (61). It has been shown to grow between 45 and 75 °C, though poorly below 50
°C, and has not been observed to cause disease in humans (60). Its spores are commonly
employed as biological indicators in steam sterilization processes (36). Comparatively little has
been studied on these spores. The outer coat is reported to be thinner than other Bacillus species,
7

yet interestingly, G. stearothermophilus makes one of the largest of the Bacillus-related spores
(45, 50, 62).
Naked Viruses
General Structure and Characteristics
Viruses can be broadly classified into
two categories: naked (hydrophilic) and
enveloped (lipophilic). Naked viruses include
those from the following families:
Adenoviridae, Papillomaviridae,
Polyomaviridae, Reoviridae, Caliciviridae,
Picornaviridae, Astroviridae, Hepeviridae,
Parvoviridae, and Anelloviridae. Naked
viruses have a very simple structure
consisting of a protein capsid containing a

Figure 2: Poliovirus, a non-enveloped virus

DNA or RNA genome. Viruses are obligate intracellular parasites and as such, require the use of
cell culture for scientific study. Many of them enter cells using receptor mediated endocytosis,
then release their genome into the host cells cytoplasm for replication or transport to the nucleus.
After several replication cycles, the virus progeny will typically lyse the host cell to reenter the
surrounding environment, although this strategy is not the case for all of the above listed virus
families. Their infection and replication strategies can vary significantly.
Mechanisms of Resistance
Disinfection of viruses is somewhat different than that of vegetative organisms or even
spores. The general mechanism for killing vegetative organisms with chemical biocides is by
8

destroying structures related to metabolism such as denaturation of protein or fixation of
structures to disable function. Since viruses are ametabolic, the action of many chemical
disinfectants is to inactivate them by blocking viral entry into cells or destroying the genome
(63). As such, there are much fewer targets, especially on naked viruses, on which disinfectants
can act. In addition, naked viruses can aggregate into bodies while replicating within cells that
can act as barriers to disinfection for those virions buried deep within the aggregate (63, 64).
Naked viruses are considered to be more resistant to chemical disinfectants and have greater
environmental stability than enveloped viruses (65, 66). Two examples of naked viruses will be
discussed below.
Poliovirus
Human poliovirus is a small (~30 nm), non-enveloped, icosahedral, (+) ssRNA virus
from the Picornaviridae family and is known for its ability to cause poliomyelitis. As an
enterovirus, polio spreads via fecal-oral transmission and replicates in the gastrointestinal tract
using CD155 for cell entry. Poliovirus replicates in the cytoplasm and its genome is translated
into one long peptide chain that self cleaves to yield the capsid proteins comprised of VP1, VP2
and VP3, as well as various replication components including an RNA-dependent RNA
polymerase and an RNA helicase. How poliovirus lyses and exits cells is not fully understood
(67). There are three serotypes of poliovirus designated type 1 (Mahoney), type 2 (Lansing), and
type 3 (Leon), with type one being the most prevalent and most often used in virucidal testing. In
a report by the CDC, the last reported case of type 2 poliovirus was in India in 1999, while no
incidences of type 3 poliovirus have been reported since November of 2012. Type 1 has still
been reported in Europe and the West Pacific (68). Poliovirus displays significant resistance to
biocides and is often used in virucidal disinfectant testing, since it is relatively easy to culture
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(69-71). Disinfectants effective against poliovirus include hypochlorite, aldehydes, and peroxide
(63). Ethyl alcohol is effective against poliovirus producing a 4 log kill in less than 3 minutes,
while isopropyl alcohol seems to have little to no effect on the virus at all (72, 73). GTA shows
good virucidal activity (> 3 log10 reduction) after 3 minutes against poliovirus (71, 74, 75). From
1991 to 2004, a series of papers were published on GTA’s effect in low concentrations on
poliovirus and its capsid proteins. They concluded that location of lysine residues on VP1’s
surface were related to level of glutaraldehyde inactivation of poliovirus (75-77).
Human Papillomavirus
Human papillomavirus (HPV) is another small (~50 nm) non-enveloped circular dsDNA
virus. HPV infects keratinocytes at the base of the epidermis and as a result of infection, can
create warts, and in some cases, cancer. HPV-16 and 18 are best known for their role in causing
genitorectal cancers in men and women (78, 79). HPV is non-cytolytic and does not induce
visible cytopathic effects in traditional cell cultures. It is difficult to culture in vitro since its
replication cycle is tied to the differentiation state of the epidermal tissues it infects. Organotypic
raft cultures were developed in the 1990’s to allow HPV to be grown in vitro (80). Because of its
difficulty to culture and lack of an infectious virus assay, there was very little known about the
susceptibility of HPV to chemical disinfection until recently. Saitanu suggested in 1975 that
viruses from the then Papovaviridae family may be more resistant, given their greater
environmental stability (81). Recent developments have allowed HPV disinfections studies to be
done. Viable HPV can be quantified by PCR amplification of the spliced E1^E4 mRNA
produced by HPV upon successful infection (82). In 2014, our lab published the first known
disinfectant susceptibility data for HPV-16. We showed that HPV-16 displays resistance to low
level, broad spectrum disinfectants such as alcohols and phenols, similar to enteroviruses and
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other naked viruses. HPV-16 however was found to be completely resistant to commercial GTA,
even at extended contact times (82).
Disinfection
Types of Disinfection and the Spaulding Classification
There are two categories of pathogen-destroying agents: those that are used on animate
surfaces (antiseptics) and those used on inanimate surfaces (disinfectants). The goal of
disinfection is to remove or kill infectious pathogens from objects that could possibly transmit
these organisms. Sterilization is defined as the complete absence of life. To further classify
disinfectants, Earl Spaulding published a paper in 1939 on the disinfection of medical
instruments in relation to how and where the instruments were used (83). He divided medical
instruments into three categories; Critical, Semi-critical and Non-critical, which called for
treatment by sterilants, high level-disinfectants, and low-level disinfectants, respectively.
Critical instruments are those that if used when contaminated would pose a high risk for
infection. These instruments are typically used in sterile body sites such as the cardiovascular
system and are therefore required to be sterilized using an autoclave at 121 °C for a
recommended time. For instruments that are water or heat sensitive, liquid chemical sterilants,
such as GTA were recommended as a substitute (83, 84).
Semi-critical instruments are those that contact mucus membranes or non-intact skin.
This includes endoscopes, anesthesia equipment, etc., and as such, must be processed minimally
using high-level disinfectants, such as hydrogen peroxide, glutaraldehyde, ortho-phthaldehyde or
peracetic acid. The FDA defines a high-level disinfectant as a “sterilant used for a shorter contact
time to achieve a 6-log10 kill of an appropriate Mycobacterium species” (72).
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Non-critical instruments would be things that contact intact skin, such as stethoscopes, or contact
thermometers. These can be disinfected with alcohols, quaternary ammonium compounds, or
halide-based disinfectants. Intermediate disinfectants have also been added as a category for the
disinfection of semi-critical instruments that have contact with areas of the body such as nonintact skin or mucosal tissues (72, 83). Disinfectants can further be classified functionally as
bactericidal, tuberculocidal, fungicidal, virucidal and sporicidal, to more clearly indicate the
types of organisms they can kill. Organized in Table 1 are the various classifications for
instruments and the levels of disinfection required for each class, as described by Spaulding and
updated by the CDC.
Table 1: A simple representation of the Spaulding Classification. Information taken from:
http://www3.gehealthcare.com/en/Products/Categories/Ultrasound/~/media/Images/Product/ ProductCategories/Ultrasound/probe_care_chart.gif
Classification

Definition

Level of Disinfection Required

Test Organism

Critical

Device enters otherwise sterile
tissue

Sterilization

Endospores

Semi-Critical

Device contacts mucous
membranes or may come in
contact with unhealthy or nonintact tissue

High

Mycobacteria

Non-critical

Device contacts intact skin

Intermediate

Small Non-enveloped
viruses

Non-critical

Device contacts intact skin

Low

fungi, yeasts, enveloped
viruses, vegetative
bacteria

Disinfectant Testing
In 1881, Robert Koch published a forty-eight page study entitled “On Disinfection”
which was one of the first real comprehensive studies on the ability of chemical disinfectants to
destroy bacterial endospores (85, 86). A few years later in 1897, Kronig and Paul published a
study in which they observed that bacteria are not all disinfected similarly, and kill rates
depended heavily on factors such as contact time, concentration of the disinfectant, and
12

temperature of the reaction. They were also the first to use a survivors per plate count method to
determine a disinfectant’s biocidal activity (87). In 1903 Rideal and Walker introduced phenol as
a standard for comparison of disinfectants, and standardized methods such as growth conditions,
media and specific bacteria for use in disinfectant testing. This would lay the foundation for the
standardized methods for testing chemical disinfectants used today (86, 88). Virucidal testing
would come much later with the development of cell culture methods.
Currently there are several standardized methods available to test the efficacy of
disinfectants in different scenarios and against different types of organisms (86). AOAC
International and the American Society for Testing and Materials (ASTM) have published many
of these methods, several of which are employed by government agencies for validating the label
claims of commercial disinfectants.
There are three general kinds of disinfection tests: suspension, carrier and in-use or field
tests. Suspension tests are useful for determining the potency of a disinfectant against the
organism of interest while suspended in a solution such as physiological saline. At predetermined
contact times, aliquots of a disinfect/organism suspension are removed and sub-cultured for
survivor counts. The conditions of the test can be manipulated in many ways for a variety of
possible scenarios, such as the addition of protein to simulate a bioburden. These tests, however,
are limited in their ability to accurately predict kill times in more realistic situations and as such,
represent an ideal scenario for the disinfectant. They are often used as preliminary tests (63). The
ASTM method E231-03 is an example of this type of test (86).
Carrier tests employ the use of a small smooth surfaced object that is inoculated with the
test organism and dried, in an attempt to better simulate disinfection of a contaminated hard
surface. The carrier is then treated with disinfectant for predetermined contact times. The
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disinfectant on the carrier is then neutralized either by dilution or by a neutralizing solution, after
which it is placed in recovery medium and incubated for several days. Positive cultures indicate
the failure of the disinfectant to kill all of the intended organisms. Although they better simulate
disinfection in real-life scenarios, carrier tests are prone to inconsistency, due to a number of
factors including carrier condition, organism preparation, neutralizing method, etc. (86, 89). This
topic will be discussed further later.
In-use tests are usually an extension of, or are used to validate the results of the two
previous types of tests. These types of tests are usually the application of the disinfectant being
tested in a real-life setting. In-use tests involve disinfecting a test instrument using the protocol
designed for it, then washing or swabbing for viable survivors. Generally, these tests aim for
complete kill after the required contact time (86).
Approval of Chemicals used in the Reprocessing of Medical Instruments
The United States Food and Drug Administration (FDA) is the regulating body for claims
involving liquid chemical sterilants used on reusable medical instruments (84). The regimen of
tests required to qualify an agent as a liquid sterilant is quite rigorous and expensive. The
manufacturer must provide documentation of testing for potency of the proposed sterilant using
AOAC Official Test Methods 966.04 (sporicidal carrier test), 965.12 (tuberculocidal carrier test),
6.2.01:1995 (Salmonellicidal, Staphylococcocidal and Pseudomonacidal), 964.02, and the EPA
approved virucidal test DIS/TSS-7. In addition to these tests, the manufacturer must provide
evidence of a simulated-use test proving that a Sterility Assurance Level (SAL) of 6 can be
achieved by the disinfectant. The SAL refers to the time require to kill a certain quantity of
organisms, in this case 6 logarithms or 106 spores. The FDA requires the use of Bacillus subtilis
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spores for this test. Finally the manufacture must provide confirmatory results to the simulateduse test with an in-use test (84).
AOAC Sporicidal Test Method
For liquid chemical sterilization and sporicidal disinfection in clinical settings not
associated with the use of medical instruments, the United States Environmental Protection
Agency (EPA) is the regulating body. They recommend the use of AOAC method 966.04 for
testing disinfectant efficacy and require the use of two kinds of carriers with spore concentrations
of ~106 CFU per carrier.
AOAC Method 966.04 is a carrier style test intended for liquid and gaseous chemical
disinfectants. It employs the use of spores from Bacillus subtilis and Clostridium sporogenes,
which are dried onto either porcelain penicylinders or silk suture loop carriers. These are then
submersed in the test disinfectant for the recommended contact time. The carrier is then removed
from the disinfectant and added to nutritive broth which is incubated for 21 days. If no growth is
observed, the tubes are heat shocked and incubated for an additional 72 hours. If no growth is
observed after these incubations, the culture is reported as negative. In order to be considered
sporicidal, a disinfectant must effect at least 59 of 60 replicates as negative. In order to be
considered a sterilant, no cultures can test positive after the given incubation period (90). For
disinfection claims against Clostridium difficile spores, manufactures must test C. difficile spores
on carriers as well (84).
ASTM Virucidal Test Method
In general, virucial testing is used to indicate intermediate level disinfection, although
this is not a hard and fast rule. For example, poliovirus and some other small naked viruses are
not readily inactivated by isopropyl alcohol, which is often considered an intermediate level
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disinfectant and easily kills most vegetative bacteria (73). Virucidal testing requires >104 viable
virus particles per carrier with an effective exposure time less than or equal to 10 minutes. The
EPA recommends ASTM 1053-11 for validating virucidal efficacy claims for disinfectants, as
well as testing with the intended target virus to be listed on the label of the disinfectant (63, 91,
92).
ASTM Method E1053-11 is also a carrier style test intended for testing liquid or
aerosolized disinfectants. This method involves drying virus as a film onto a carrier, then
incubating with the test disinfectant. At the appropriate contact time the virus is diluted in buffer
or neutralizing buffer and then assayed for infectivity in appropriate cell cultures. This method
recommends that at least one non-enveloped virus in addition to the virus of interest is tested to
demonstrate broad virucidal activity. Non-enveloped viruses are typically used for this method
since they exhibit greater resistance to destruction than enveloped viruses. This test is also more
difficult to perform than most sporicidal or bactericidal tests since the use of cell culture is
required to count surviving viruses.
Test Method Associated Discrepancies in Disinfection Data
As described above, the FDA specifies a number of AOAC and ASTM methods for the
validation of disinfectant claims. In the last 40 years, there have been numerous reports of
inconsistencies in the accuracy and reproducibility of these test methods, especially amongst
carrier tests (93-99). Many of the discrepancies studied have been found to be a result of the
factors associated with the test method; i.e. carrier washing methods, recovery media,
neutralization methods, and so forth. In 1990, Cole et al. showed that the neutralizing solution in
the approved AOAC method for testing tuberculoicdal activity was bacteriostatic, and therefore
made results from that test unreliable (93). The AOAC sporicidal test used to validate liquid
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sterilant and high level disinfectant claims has also been criticized as being inaccurate and
having inconsistent results, due to test method factors (100-105). In 1995, Miner showed that
homogenization and filtration of the spore suspension by various methods not specified in the
test, affected the ability of glutaraldehyde to effectively disinfect spores, resulting in false
positives. They also evaluated the effect of carrier history on the generation of randomly positive
carriers, and showed that newer carriers tended to have more false positives as a result of cracks
and pits that could protect spores from GTA disinfection (89, 105). Loyd-Evans showed in 1986
that recovery of viruses from carriers depended on the carrier type and porosity, which lead to
variable results in the determination of viral infectivity after disinfectants were tested (106).
Organism Associated Discrepancies
Even when tests methods are refined and strictly controlled, there can still be a significant
difference in disinfection results from lab to lab. Poliovirus is known to be susceptible to
glutaraldehyde. However, strain related differences in disinfection susceptibility have been
observed between reference strains and wild strains of poliovirus, with some of the clinical
isolates proving to be more resistant than the type strains. The authors suggested that the
differences in kill times for these viruses was likely due to slightly different capsid amino acid
sequences. (107). Previously our lab tested the efficacy of chlorine, a quaternary ammonium
compound and glutaraldehyde against 5 Mycobacterium bovis isolates provided by certified
disinfection testing laboratories, using the EPA approved tubreculocidal method, and found there
were significantly different kill times as well as phenol resistances between the isolates (108). It
is reasonable to conclude as well that high titer bacterial and even viral suspensions contain
enough organisms that subpopulations begin to arise that may change the kinetics of how the
suspension will disinfect.
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Generally the use of surrogates for target organisms is accepted if the organism of interest is
difficult to culture or dangerous to work with. There are numerous criterion that may be used to
select surrogate test organisms (86, 109, 110). Table 2 show a small list of target organisms and
their surrogates, as well as some of the reasons for choice of the surrogate.
Table 2: Examples of Surrogates from: Criteria for Selection of Surrogates Used To Study the Fate and
Control of Pathogens in the Environment (110)
Case

Target

Practical

Biological

Surrogate

Fomite survival of
anthrax

B. anthracis

safety, cost

morphology, genetic
relationship

B. thruingensis, B. subtilis,
B. atrophaeus

coliforms

common in
environment

similarity

Kelbsiella terringena, E.
coli

viruses

common in
environment

Morphological
similarity, resistance

Poliovirus, Rotavirus

cyst forms

common in
environment

resistance, functional
morphology

Cryptosporidium parvum

Disinfection-medical

M. tuberculosis
viruses

safety, cost,
cultivation

morphology, genetic
relationship cultivation

M. bovis BCG
poliovirus

Sterilization-food

spoilage organisms

safety, cost

resistance, cultivation

Geobacillus
stearothermophilus

Sterilization-medical

Clostridia spp.

safety, cost

Genetic relationship,
morphology, resistance

C. sporogenes, B. subtilis

Water purification

The use of surrogate organisms to predict resistance of other organisms is another source
of concern associated with these tests (82, 104, 111-113). For over 50 years, B. atrophaeus and
B. subtilis have been used as surrogates in testing decontamination procedures for B. anthracis
(86, 113). However, our lab previously showed that B. subtilis is almost 50 times more resistant
to disinfection by CIDEXTM (2.3% alkaline glutaraldehyde) than B. anthracis (104). This and
other studies have led to the presumption that B. subtilis is the most resistant of the spore
forming organisms to disinfectants. However, in this same study, we also showed that when
tested against SteriPlexTM (0.2% peracetic acid), B. anthracis was 4 times more resistant than B.
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subtilis (104). Recently our lab has shown that HPV-16, a naked virus that causes genitorectal
cancers, is completely resistant to glutaraldehyde and other common clinical disinfectants.
Glutaraldehyde is a common liquid sterilant used to sterilize flexible endoscopes. This is the first
report of a naked virus being completely resistant to glutaraldehyde (82). From these evidences,
it is plain that the use of surrogates to produce reliable generalized disinfection data, though
convenient and in some cases effective, should be done with caution and the data acquired
should be used to create clinical disinfection protocols with a reasonable degree of skepticism.
Glutaraldehyde
Structures in Solution
Glutaraldehyde (GTA) is a 5 carbon dialdehyde (1,5-pentanedial) commonly used as a
cross-linking agent. There have been several studies published on the predominant structure of
GTA in commercial and reagent grade solutions. GTA solutions typically have varying amounts
of intermediates and polymer sizes depending on pH, temperature, and concentration which can
affect its reactivity as a biocide and cross-linker (114-117). GTA can be found as a monomer,
dimer, trimer, polymer, cyclic hemiacetal, acetal-like polymer, and as a mono or dehydrate (116,
118). In acidic solutions, GTA is known to be in equilibrium between cyclic hemiacetals and
polymerized hemiacetals (119, 120). As the pH and temperature are increased GTA will begin to
undergo an aldol reaction and subsequent dehydration resulting in an α-β unsaturated polymer
that will continue to grow until the length of the polymer causes it to precipitate (120, 121).
Because of these myriad structures, the reactivity of GTA with other molecules can be difficult
to predict. It is also relatively difficult to manufacture GTA solutions containing high amounts of
free aldehyde. Figure 3 shows a number of the GTA structures that can be found in solution.
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Figure 3: A representation of the many forms of aqueous glutaraldehyde and changes induced by
increasing pH (116).

Chemistry and Reaction with Various Biomolecules
GTA exhibits aldehyde chemistry at both ends with a variety of nucleophiles such as
deprotonated amines. In this particular reaction, a primary amine will attack the carbonyl carbon
of the aldehyde group in nucleophilic addition to form a carbinolamine. This will dehydrate to
form an imine, the final product of the reaction (122). Figure 4 shows the general reaction of an
aldehyde and an amine and the end product.
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Figure 4: Reaction of glutaraldehyde with a primary amine
GTA was first employed as a tissue fixative for electron microscopy in 1963 and has
since found numerus uses including chemical disinfection and leather tanning (123). GTA’s
reactivity with side chains of amino acids and proteins under various conditions has been studied
in depth. The reactivity of GTA with glycine, serine and proline peaks at around pH 6-7 while its
reactivity with lysine and arginine keeps increasing with pH (122, 124-126). Generally,
aldehydes, including GTA, react with amines to produce imines via nucleophilic substitution. In
addition to primary amines, GTA has also been shown to have limited ability to interact with
several other functional groups on proteins, such as secondary amines, thiol, phenol, imidazole,
guanidyl and hydroxyl groups (116, 127, 128). Of all these groups, previous studies suggest that
the ε-amine group on lysine is most likely the main functional group involved in protein
crosslinking (116, 129). Woodroof proposed that GTA protein crosslinking is carried out through
the reaction of free aldehyde with lysine residues on the same protein or between proteins to
form a pyridinium salt similar to desmosine (130). Another study showed that GTA reacts with
the ε-amino groups on diaminopimelic acid, a carboxylated derivative of lysine, in B. subtilis
peptidoglycan (131). The interaction of GTA with other vital biomolecules such as
carbohydrates, lipids and nucleic acids, has not received much attention (132, 133). Studies in
cell models showed that GTA would preferentially bind to nuclear protein and histones before
DNA. Nucleic acid crosslinking was also shown to be temperature dependent (134). Limited
RNA fixation has also been documented in poliovirus, though it is still not thought to be as likely
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a candidate for GTA reactivity (75). There are lipids that contain primary amine groups that
could react with GTA such as phosphytidylserine and phosphotidylethanolamine, though again,
there is little data to support that it plays any major role in GTA’s ability to kill microbes (116,
127).
Sporicidal Activity
GTA’s sporicidal activity is likely one of its most important and useful properties. It is
the most effective sporicidal aldehyde known, killing spores effectively at a ~2% concentration
(114, 135, 136). Studies have shown GTA to be able to kill 106 spores from both Bacillus and
Clostridium species in under 3 hours, with B. subtilis spores proving to be one of most resistant.
Spores from B. anthracis and C. difficile are typically killed in under 10 minutes (115, 137, 138).
Although there are more powerful sporicidal compounds than GTA, it has some significant
advantages to other chemical disinfectants. GTA is non-corrosive and has low toxicity, and
retains its sporicidal activity in the presence of considerable organic matter (127, 139). Under
acidic conditions, GTA can be stored almost indefinitely, until an alkalinizing agent is added for
better sporicidal action (121, 140). Currently it is thought that GTA kills bacterial endospores by
crosslinking proteins important in germination of the spore, though the exact location GTA acts
is not well known. Crosslinking of vital proteins could inactivate spores by making them unable
to transmit environmental signals favorable to spore germination. Studies have also documented
that GTA does not kill by fixing DNA (23, 132, 141).
Virucidal Activity
GTA is an effective virucide. In the original article describing GTA’s biocidal activity,
GTA was tested against an array of viruses including Poliovirus-1 and 2, Coxsackie virus,
Influenza A-2 and Herpes Simplex, all of which were inactivated in less than 10 minutes (140).
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Later studies showed enveloped viruses to be more susceptible to GTA than non-enveloped
viruses (69). As was noted earlier, HPV-16 is the only known organism that is completely
resistant to GTA disinfection.
Effect of Concentration
GTA has been tested at various concentrations in an effort to determine the optimal
concertation for efficient sporicidal action. At concentrations of 1 and 2%, GTA has been shown
to be more effective than a 4% formaldehyde solution. Lower concentrations (0.1%) are shown
to be sporostatic. Currently commercial GTA disinfectants are sold as a 2.3% solution in alkaline
or acid (115, 138, 140, 142).
Effect of Temperature
As a crosslinker, GTAs reactivity increases and decrease with temperature (114, 119,
143). Studies have also shown that at room temperature, GTA acts effectively as a sporicide and
high level disinfectant, and its sporicidal activity increases with temperature (120, 144).
Effect of pH
After concentration, GTA solution pH seems to be the most significant factor in the
sporicidal activity of GTA. Studies have repeatedly documented the effect of pH on the biocidal
activity of GTA (137, 145, 146). Although acid GTA has been shown to be much more stable
than alkaline GTA, it also exhibits slower sporicidal activity than basic solutions (142). As a
result, many commercial GTA solutions use 0.3% sodium bicarbonate as an activator and buffer.
As was described earlier, the addition of alkalinizing agents allows GTA to self-polymerize more
rapidly, leading to a loss of free aldehyde necessary for crosslinking (147). Ultimately, while
GTA kills spores faster at alkaline pH, it also losses its sporicidal activity with time on the order
of days and weeks. One suggested reason for acid GTA’s weaker sporicidal action is the loss of
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deprotonated primary amines as a result of the acidic environment. Acid GTA is also thought to
not be able to penetrate as deep into spores as alkaline GTA (137).
Effect of Sodium Bicarbonate
Some studies have suggested that sodium bicarbonate, in addition to being an alkalinizing
agent, also acts on endospore coats by some not well understood mechanism(s) to make them
more penetrable to GTA. The pH of the solution alone does not fully explain alkaline GTA’s
increased sporicidal activity. Power showed that the addition of NaOH as an alkalization agent
does not improve GTA’s activity to the same degree as bicarbonate (114, 137). Sodium
bicarbonate is hypothesized to disrupt spore coats in such a way as to make them more
permeable to GTA. The ability of GTA to penetrate deeper into endospores allows it to act on
targets that may be more sensitive than the spore coat, such as the cortex or possibly even the
core where proteins vital to germination are located. Gorman et al. showed using electron
microscopy that when adding bicarbonate to spore suspensions, the spore coats from B. subtilis
are less tightly associated with the spore, and show areas of decreased density when compared to
non-treated spores (137). Cheung suggested that sodium bicarbonate may interact with the
carbonyl groups on acidic amino acid residues in protein. This was thought to alter spore coat
structure negatively, and may possibly explain the observations of Gorman. The same study
showed that 0.3% sodium bicarbonate was able to inhibit spore germination (137, 148).
Clinical Use
GTA is still one of the most widely used liquid sterilants for reusable medical instruments
such as endoscopes, bronchoscopes, etc (149). It is recommended that endoscopy clinics soak
instruments in GTA for at least 10 minutes for normal patients with an increase to 20 minutes for
patients with known HIV and pulmonary TB infections (118). It has also been recommended for
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use in disinfecting dental equipment, cystoscopes, food containers, hemostats and anesthetic
equipment (150-152). CIDEXTM is a commonly used commercially available alkaline GTA
solution. The manufacturer recommends a 45-minute soak time for high level disinfection and a
10-hour soak time for sterilization, for the processing of semi-critical and critical medical
instruments, respectively. CIDEXTM is recommended for use up to 14 days after activation.
Amine Reactive Probes
Structure and Properties
Molecular ProbesTM has created a wide variety of amine reactive probes for use in flow
cytometry and other fluorescent applications. These probes can be separated into three separate
categories: activated esters, isothiocyanate esters, and sulfonyl chlorides. This section will focus
mostly on the activated esters which includes N-hydroxysuccinimide esters and tetrafluorophenyl
esters. These esters generally react with primary amines to form a stable carboxyamine in a pHdependent reaction. Generally a pH of around 8.3 is required for good bioconjugation. Although
bioconjugation with these functional groups can increase with pH, these esters also can
hydrolyze in aqueous solution to form non-reactive carboxylic acids in a reaction that increases
with pH. These probes show little reactivity with other functional groups associated with
proteins, even with other amino acids containing amines on their side chains. They have been
shown to be almost unreactive with other amine containing amino acids such as glutamine,
asparagine, narginine, and histidine, as well as with amines on adenosine and guanosine bases
(153).
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N-hydroxysuccinimide and Tetrafluorophenyl Esters
N-hydroxysuccinimide (NHS) esters are used commonly in bioconjugation of molecular
probes to proteins via acylation of ε-amino group on lysine residues as stated above. In addition
to the reactivity listed above, NHS –esters have also been shown to have very low reactivity with
hydroxyl functional groups found on amino acid side chains, and this only occurs when the probe
is added in significant excess and with much longer reaction times than those typically used for
bioconjugation. NHS-esters are also susceptible to hydrolysis in aqueous solution, though this
side reaction is observed to be slow at a pH less than 9. The 2,4,5,6-Tetrafluorophenyl (TFP)
esters have similar properties and reactivates to the NHS ester probes, but are less resistant to
spontaneous hydrolysis than the NHS ester group (153-155).
Alexa FluorTM Amine Reactive Dyes
Since the discovery of green fluorescent protein in the 1960’s, the use of fluorophores in
science, especially in biology, has become extremely popular. Fluorophores are particularly
useful in biology due their ability to be selectively excited and give good contrast in samples
being studied. The Alexa FluorTM dyes are a series of fluorophores developed by Molecular
Probes Inc. They were designed to have high fluorescent yields and high photostability. They are
currently sold as a wide variety of bioconjugates and commonly employed in immunology to
stain cells using antibody conjugates of the dye, but they can be attached to other biomolecules
as well (156-158). The Alexa Fluor 488 TFP-ester is a fluorescein derivative with an excitation
maximum at 488 nm and an emission maximum at 525 nm (153). The Alexa Fluor NHS/TFP
dyes have been used to label surface protein on various organisms. (159-161). In 2008, Boyana
et al. labeled Bacillus anthracis spores using the Alexa Fluor 488 NHS-ester dye to visualize
spores that had been phagocytosed by macrophages (161). In 2010, Zhang et al. described a
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method for labeling live Dengue virus using a similar fluorescent dye for use in infectivity assays
(159, 160). Figure 5 shows the structures of the Alexa Fluor dyes used in this study.

Figure 5: Structure of the Alexa Fluor dyes used in this study.
Taken from:
http://www.thermofisher.com/content/dam/LifeTech/Documents/chemstructures/images/36236.j
pg, http://www.lumiprobe.com/img/p/structure/sulfo-cy5-nhs-ester.gi
NHS Activated Gold Nanoparticles
Gold has had useful scientific, as well as obvious practical value since the early years of
the scientific method. Gold is a Nobel Metal and as such, has several desirable properties such as
being inert under standard conditions, resistant to oxidation and is non–toxic. Typically, gold
colloids are produced synthetically by growing crystals from gold ions, although there has been a
fair amount of research into the use of microorganisms to produce gold nanoparticles (162). The
use of gold nanoparticles (AuNPs) has been gaining traction in the field of biology, as a result of
the above characteristics, as well as the improved ability to functionalize AuNPs for
bioconjugation, for example with NHS groups. AuNPs have also been used for years in electron
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microscopy as size indicators, as well as catalysts. Current research is being done to improve the
use of AuNPs in immuno-sensing using AuNP-conjugated antibodies (163, 164). Bioconjugation
of proteins with AuNPs for visualization in electron microscopy is one of the most common uses
of gold colloids in biology. Although there have been a number of studies published on the
immune-sensing and protein conjugation properties of AuNP conjugates, not much has been
done in the way of labeling organisms using the non-specific binding of NHS-activated AuNPs.
One study did investigate the use of AuNP-conjugated adenovirus to carry AuNPs to tumor cells
for photothermal cancer therapy (165). Figure 6 shows a representation of the linkage between a
gold colloid (yellow-orange) and its NHS functional group via a polyethyleneglycol (PEG) linker
arm.

Figure 6: Representation of NHS Gold nanoparticle with PEG linker.
Taken from: http://www.cytodiagnostics.com/store/pc/catalog/NHS-Activated-GoldNanoparticles-Category.jpg
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Current Study
It is apparent that the current methods used for testing disinfectants for use in clinical
settings are not entirely reliable for determining an organism’s resistance to a given disinfectant
in real life scenarios. This comes in part as a result of a lack of reliable testing methods, and only
a simple understanding of the damaging mechanism(s) of many chemical disinfectants. This,
combined with the physiological variability seen among various organisms and their approved
surrogates, makes predicting and extrapolating disinfection trends a difficult task. In addition, it
is known that the testing and approval methods for registering disinfectants with their various
label claims, are time consuming, laborious and expensive. The ability to quickly and efficiently
predict kill times for various organism/disinfectant combinations would be invaluable.
Our recently published HPV-16 and HPV-18 disinfection data also demonstrates the need
for alternative methods to predict disinfection susceptibility, especially for those organisms that
are difficult to culture or are untestable due to logistical constraints.
The goal of this study is to investigate the relationship between endospore and nonenveloped virus resistance to GTA and the prevalence of available primary amines on the surface
of these organisms. Since GTA has been shown to preferentially react with lysine residues on
exposed proteins, it may be possible to quantify the relative amount of amines available to GTA
using amine-reactive dyes and labels. These could be quantified on bacterial endospores, using
mean fluorescence generated by the amine-reactive Alexa Fluor 488 TFP ester dye, and on
viruses by quantifying binding of small, activated NHS-Gold nanoparticles.
To do this, we first studied the labeling profiles of various bacterial spores, and compared
them to their corresponding 6-log reduction times when treated with GTA.
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Similar experimentation was performed with non-enveloped viruses. Two small, nonenveloped viruses were used in these studies: poliovirus, known to be inactivated by GTA, and
HPV, known to be resistant to GTA. Viruses were stained with 5 nm AuNPs and visualized with
electron microscopy. The number of AuNPs attached to capsid proteins was evaluated for each
virus. This was then compared to the known GTA susceptibilities of these viruses.
In addition to fluorescent labeling, electron microscopy was also performed on
endospores to investigate the possible correlation between spore coat thickness and other factors
with GTA kill times.
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Materials and Methods
Bacterial Strains and Spores Production
Bacillus anthracis Stern 1043, Bacillus subtilis ATCC 19659, Bacillus atrophaeus ATCC
51189, and Bacillus pumilus ATCC 7061 were maintained on Columbia (BD Diagnostic
Systems) medium and grown at 37 °C. Spore suspensions were prepared using the method of
Leighton and Doi (18). Spore stock solutions were quantified by serial dilutions and viable
plating. Stocks typically yielded between 1x108 - 1x109 CFU/ml. Suspensions were stored at 4
°C until use. Geobacillus stearothermophilus ATCC 12980 was maintained on Columbia
medium at 55 °C. Spore suspensions were created by growing lawns of G. stearothermophilus
on nutrient agar supplemented with Mg+2, Mn+2, Ca+2, K+ and Fe+2 ions at 55 °C for 8 - 10 days,
until spores made up greater than 90% of the culture (19). Spores were then harvested by adding
cold PSS + 0.01% Tween 80 to plates, scraping off the spores, and centrifuging at 4000 x g for
15 minutes. Washing by centrifugation was repeated 5 times and suspensions were checked for
purity before storage at 4 °C until use.
Viruses and Viral Growth
Poliovirus-1 Mahoney strain (PV-1) kindly provided by Dr. Dale Barnard, Utah State
University, was grown, purified, and titered as previously described (166). Human Papilloma
Virus 18 (HPV-18) was kindly provided by Dr. Craig Meyers at Pennsylvania State University
and was stored at -80 °C until use in labeling studies.
Spore Labeling and Flow Cytometry
Spores were labeled according to a modified protocol from Boyana et al. Suspensions
were adjusted to 1x107 CFU/ml, then diluted 1:10 in PSS + 0.01% Tween 80 and 0.1 M sodium
bicarbonate, pH 8.3 (wash buffer) to give approximately 106 CFU/ml. Desiccated Alexa FluorTM
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488 TFP-ester (AF488) dye was re-suspended in sterile DMSO to give a final concentration of
1µg/µl. Fifteen µl of dye was added to each of the spore suspensions, which were incubated in
the dark for at least 2 hours at room temperature. Unbound dye was removed by centrifuging at
14,000 x g for 30 minutes, and washing the suspensions three times in 1 ml of wash buffer.
Prepared samples were kept at room temperature in the dark until use in a Blue/Red Applied
Biosystems Attune Flow Cytometer (14). Since spore preparations were all greater than 90%,
bright phase spore gates were made around populations that showed relatively high side scatter
and low forward scatter, suggestive of spore complexity and size respectively, to reduce noise
from other particulates and contaminants. Unstained spores were used as standards for gating
stained spore populations. Runs were done in triplicate, and each experiment was performed six
times. Raw data was processed using FlowJoTM where fluorescent means were obtained by
gating on spores, then sub-gating peaks to exclude extreme outliers and unstained spores.
Suspension Tests
All spore suspensions were tested against GTA using the ASTM Standard Guide for
Assessment of Antimicrobial Activity using a Time-Kill Procedure, designated E2315-03. Onehundred μl of a 109 CFU/ml spore suspension was added to 9.9 ml of GTA and incubated at 20
°C for predetermined contact times. At the given contact time, 1 ml of this GTA-spore
suspension was added to 9 mL of 1% glycine for at least 5 minutes, before serially diluting the
suspension further to predetermined dilutions. One ml from these dilutions were then plated in
triplicate onto Columbia agar using membrane filtration, and incubated at 37 °C (55 °C for
Geobacillus spores). Colonies on each membrane were counted at 24 and 48 hours. The average
number of survivors per plate were used to determine the Log10 reduction in spores for each
contact time. Tests were plated in triplicate and replicated three times using four contact times

32

per test. Time-Kill regression curves and 6-Log10 reduction estimates were generated using
MinitabTM from contact times and their associated Log10 reductions.
Glutaraldehyde
CIDEXTM (2.3 % alkaline glutaraldehyde) was purchased from Advanced Sterilization
ProductsTM and was activated prior to use in disinfection tests.
Fluorescent Quenching Assay
To test the ability of GTA to inhibit binding of AF488 to bacterial spores, stock spore
suspensions were diluted to approximately 107 CFU/ml and 100 μl of this stock was added to 900
μl of GTA. Spores of B. anthracis were incubated for 5, 10, 15, and 30 minutes before 1ml of
6% glycine was added to neutralize the reaction. B. subtilis spores were incubated for 45, 90, 130
and 150 minute contact times. The spores were then washed 3 times at 14,000 rpm for 30
minutes and re-suspended in wash buffer to remove the glycine-GTA solution. Ten μg of AF488
was added to each tube and these suspensions were incubated at room temperature in the dark for
at least 2 hours. Once staining was complete, the suspensions were washed 3 times as described
above and analyzed by flow cytometry. Generated peaks were analyzed and mean fluorescence
was recorded in triplicate. Each spore species was tested three times.
Protection Assay
To test the ability of AF488 to block GTA sporicidal activity, 107 spores were stained
with 100 µg of Alexa Fluor 647 NHS-ester (AF647) for 2 hours. AF647 was used in the place of
AF488 (TFP-ester) for this experiment because of the presence of a primary amine on AF488
that could possibly react with GTA. The Alexa Fluor NHS-esters exhibited the exact same
reactivity as the TFP-esters (167). After incubation at room temperature, the stained suspensions
were washed three times as described above and re-suspended in 1 ml of wash buffer. These
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suspensions were then used in a modified version of the ASTM Time-Kill Suspension test.
Instead of 100 μl of this suspension, 1ml of stained spores were added to 9 ml of GTA.
Spore Coat Removal
Spore coats were removed as described earlier (137, 168). About 108 spores were
suspended in de-coating solution (containing 8 M urea and 10% 1-mercaptoethanol) and
incubated at 60 °C for 60 minutes. Spores were then washed three times at 10,000 x g with cold
PSS and re-suspend in cold PSS with 0.01% Tween 80.
Viral Labeling
Five nanometer NHS activated Gold Nanoparticles (AuNPs) were purchased from
Cytodiagnostics and used to stain 107-108 PFU of either PV-1 or HPV-18, according to the
manufacturer’s instructions. Briefly, each virus was purified through a sucrose gradient and resuspended in protein resuspension buffer (Cytodiagnostics). Sixty ul of virus in buffer was then
added to 48 ul of reaction buffer (Cytodiagnostics) and the mixture was added to a vial
containing 0.1 mg of lyophilized AuNPs. This mixture was then shaken to homogenize and
incubated at 22 °C for 2 hours. Ten µl of quencher solution (Cytodiagnostics) was added, then
the reaction mixture was diluted in 3.9 ml of PBS (pH 7.3). The mixture was then placed in an
Amicon® Ultra-4 MWCO 100K ultrafiltration membrane tube and spun at ~3000 x g for 3
minutes, or until only 250 µl of solution remained on top of the filter. About 3.75 ml of PBS was
added to each tube and the flow through solution was discarded. This was repeated 3 times to
also exchange buffers. The last centrifugation was used to concentrate the virus with AuNPs to a
total volume of 250 µl. These were then stored at 4 °C until preparation for electron microscopy.
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Electron Microcopy
Endospores were prepared for electron microscopy by fixing with 2% glutaraldehyde
overnight. Spores were washed and then fixed with OsO4 for 3 hours. After fixation, spores were
embedded in 2% LMP agar and dehydrated using an acetone series. Spore-agar pellets were then
soaked in 50% acetone/50% resin of Spurr for 4 hours, two times, and then 100% resin
overnight. Spore pellet-resin solutions were then cured overnight at 70 °C. Thin sections were
cut to a gold color and stained with 2% uranyl acetate and lead citrate. Thin sections were then
attached to copper grids with formvar-carbon supports and imaged in a FEI Helios Nanolab 600
by STEM.
After viruses had been labeled with AuNPs, 20 µl of labeled virus and 2%
phosphotungstic acid (PTA) were placed on parafilm. A 300 mesh copper grid coated with 3 nm
amorphous carbon (TedPella) was then floated on the labeled virus for 1 minute. Excess virus
was wicked off the grid with filter paper, and the grid was then placed on the PTA for 1 minute.
Excess stain was also wicked off the grid and girds were allowed to dry. Grids were then imaged
with a Tenaci F30 or F20 by TEM.
Blocking AuNP Binding PV-1 using GTA
Prior to labeling with AuNPs as descried earlier, PV-1 was incubated with 2%
glutaraldehyde for 1 hour to test the ability of GTA to block AuNP binding. Preparations were
then prepped for and viewed using electron microscopy as described above.

35

Results
Comparison of Kill Curves and 6-Log Reduction Times for Different Batches of Bacillus Spores
6-Log10 reduction times were estimated by generating kill curves of 5 Bacillus species
against GTA using viable plating by membrane filtration. Each dilution was plated in triplicate
and each test was repeated 3 times. Figure 7 shows a wide range of GTA kill times amongst the
spores ranging from as short as 6 minutes to up to 2.5 hours. No significant difference was seen
between the slopes of spore batches.
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Figure 7: Comparison of Glutaraldehyde 6-Log10 Reduction Estimates for 2 different batches of
spores from 5 different species. Blue columns indicate estimates for spore batch 1, while the
orange columns indicate estimates for spore batch 2. Each column represents the mean of 3
replications. Error bars represent ± 1 standard error.
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Saturation of Spores with AF488
To determine the amount of AF488 necessary to saturate all possible binding sites on
spores, 106 CFU of B. anthracis and B. subtilis spores were incubated with 0.001, 0.01, 0.1, 1,
10, 20 and 50 µl of AF488 (1 µg /µl) for at least 2 hours. ANOVA with Tukey HSD was used to
determine statistical difference between fluorescent means. Incubation for longer than 2 hours
made no significant difference in mean fluorescence. Figure 8 shows the fluorescent peaks
generated from this experiment. Increasing the amount of dye from 20 µg to 50 µg did not result
in a significant increase in mean fluorescence for either spore type. However, increasing from 10
µg to 20 µg of dye in B. anthracis and B. subtilis did increase the mean fluorescence
significantly. The same difference was not seen in B. subtilis. Overall, it was determined that
greater than 10 µg of AF488 is required for complete saturation of binding sites on B. anthracis
and B. subtilis spores.
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Figure 8: Mean fluorescence (MFU) of B. anthracis and B. subtilis spores after staining with
different concentrations of Alexa Fluor 488. Blue circles indicate MFU for spores from B.
anthracis, while orange triangles indicate MFU for B. subtilis. Each symbol represents the mean
of 3 replications. Error bars represent ± 1 standard error. Horizontal bar indicates means with no
statistical difference at a 95% confidence level.
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Bacillus Species Fluorescent Profiles
Staining Bacillus spores with excess AF488 yielded peak shifts relative to controls. Mean
fluorescence for each peak generated by a spore was calculated. Figure 9 shows the mean
fluorescence for various spores from Bacillus species. B. anthracis displayed the most intense
fluorescence while B. subtilis displayed the least. G. stearothermophilus and B. atrophaeus
displayed fluorescent profiles similar to B. subtilis. Figure 9 shows a peak shift for stained
spores relative to controls. Statistical analysis showed that the peaks for B. anthracis and B.
subtilis were different from the other spores, but that G. stearothermophilus and B. atrophaeus
had means that were not significantly different from each other.
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Figure 9: Fluorescent profiles of Bacillus species spores. Each column indicates the mean
fluorescence (MFU) generated from each spore from batch 1. Each bar represents the mean of 3
replications. Error bars represent ± 1 standard error. Horizontal bars indicate means that are not
statistically different from each other at a 95% confidence level.
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Correlation Between Estimated 6-Log Kill Times and Mean Fluorescent Peaks
Mean fluorescent peaks data was compared with data from Time-Kill assays to
investigate a possible correlation between GTA kill times and AF488 binding to reactive groups
on spores. From Figure 10, it appears that as fluorescence decreases, kill time increases, although
it is not necessarily a linear relationship. (R2 = 0.6187)
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Figure 10: Mean fluorescence vs. 6-Log10 reduction time estimates. Fluorescent profiles were
plotted against 6-Log10 reduction estimates for B. anthracis (circle), G. stearothermophilus
(square), B. atrophaeus (triangle), and B. subtilis (diamond). Each symbol represents the mean of
3 replications. R2 = 0.6187
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Inhibition of AF488 Binding by Treating Spores with GTA
The ability of GTA to block AF488 binding to spores was tested to determine the
similarity of reactive sites between GTA and AF488. Figure 11 and Figure 12 show the mean
fluorescence generated by spores from B. anthracis and B. subtilis after treatment with GTA for
various contact times. Relative to the untreated control, there was a 1.19 log (~94%) drop in
fluorescence for B. anthracis after a 5 minute treatment with GTA. Fluorescence did not
decrease significantly as the final contact time was reached. The same trend was observed with
B. subtilis. After the initial contact time, mean fluorescence did not significantly decrease beyond
the 0.85 log (~86%) loss of fluorescence relative to unstained spore controls.
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Figure 11: Reduction in fluorescence of B. anthracis spores when pretreated with GTA for 5 to
30 minutes prior to staining with AF488. Spores + AF488 were not pretreated with GTA. Spores
+ GTA were not subsequently stained with AF488. Unstained spores were included as a control.
Horizontal bars indicate means that are not statistically different from each other at a 95%
confidence level. Each bar represents the mean of 3 replications. Error bars represent ± 1
standard error.
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Figure 12: Reduction in fluorescence of B. subtilis spores when pretreated with GTA for 45 to 90
minutes prior to staining with AF488. Spores + AF488 were not pretreated with GTA. Spores +
GTA were not subsequently stained with AF488. Unstained spores were included as a control.
Horizontal bars indicate columns that are not statistically different from each other at a 95%
confidence level. Each bar represents the mean of 3 replications. Error bars represent ± 1
standard error.
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Blocking of GTA Sporicidal Activity Using AF647
The ability of AF647 to block the sporicidal activity of GTA was investigated to further
understand the similarity of reactive functional groups used by GTA and AF647. The results are
displayed in Figure 13 and Figure 14. No significant difference was observed in the slopes of the
kill curves for either B. anthracis or B. subtilis labeled with any of the above reagents relative to
unstained controls.
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Figure 13: Log10 reduction plots for B. anthracis spores pretreated with AF647. Blue dots
indicate spores not treated with AF647 prior to tests with GTA. Orange dots indicate spores
treated with AF467 prior to testing. Each symbol represents the mean of 3 replications. Error
bars represent ± 1 standard error.
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Figure 14: Log10 reduction plots for B. subtilis spores pretreated with AF647. Blue dots indicate
spores not treated with AF647 prior to tests with GTA. Orange dots indicate spores treated with
AF467 prior to testing. Each symbol represents the mean of 3 replications. Error bars represent ±
1 standard error.
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Effect of Removing Spore Coats
Since protection was not given to spores treated with AF647, we removed the spore coats
from B. subtilis spores to investigate the ability of AF647 to bind to the spore cortex. The results
are shown in Table 3. AF647 gave no protection to spores with their coats removed.

Table 3: Effect of AF647 Staining of De-coated B. subtilis spores on Susceptibility to GTA
Spore

Contact Time

Log10 Reduction

B. subtilis

10 min

>4.5

B. subtilis + AF647

10 min

>4.5

B. anthracis

30 sec

>4.5

B. anthracis + AF647

30 sec

>4.5
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Spore Coat Thickness
Figure 15 shows comparisons of the thickness of spore coats from Bacillus spores. Coat
thickness was measured at six points on 12 spores from thin section electron micrographs using
ImageJTM imaging software. Mean coat thickness was then compared using ANOVA with Tukey
HSD. B. anthracis and B. pumilus have statistically thinner protein coats (p < 0.05) than the
other tested spores, while B. subtilis has a thicker protein coat. B. anthracis also showed a much
thinner coat than B. pumilus (p < 0.001). Statistically, the difference between coats of B.
atrophaeus, G stearothermophilus and B. subtilis is insignificant (p > 0.05).
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Figure 15: Comparison of protein coat thinckness for spores from B. anthracis (blue), B.
pumilus, (orange), B. atrophaeus (grey), G. stearothermophilus (yellow) and B. subtilis (green).
Horizontal bars indicates means that are not significantly different at a 95% confidence level.
Each bar represents the mean of 12 spores. Error bars represent ± 1 standard error.
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Figure 16: Electron micrographs of the different types of spores used in this study. Refer to
Figure 1 for a description of the different parts of a spore. Magnification is 65,000 – 150,000x
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Protein Coat Thickness Compared to 6-Log10 Reduction Estimates
When coat thickness was plotted against mean 6-Log10 reduction kill times for their
respective spores, a correlation could be seen. Figure 17 shows the relationship between spore
coat thickness and the 6-Log10 Reduction kill times for each spore type. Generally, as spore coat
thickness increased, so did the associated time required to kill the spores, although the
correlation between thickness and GTA resistance is only moderate. (R2 = 0.662)
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Figure 17: Spore protein coat thickness plotted against GTA 6-Log10 reduction kill times for
various spore species. Points on the plot indicate the average coat thickness and kill time for a
given spore. Error bars represent ± 1 standard error. (R2 = 0.662)
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Viral Staining with Gold Nanoparticles
Figure 18 shows electron micrographs of latex beads, PV-1, and HPV-18 before and after
labeling with gold nanoparticles. Although PV-1 (Figure 18D) is not completely surrounded by
AuNPs, it is associated with the AuNPs either in large clusters as seen above, or with a few
nanoparticles closely associated with the virus. In the case of HPV-18 (Figure 18 F), no such
association is seen. It is important to note that the NHS groups attached to the AuNPs are linked
to the particles by a 5kd PEG linker arm. These linkers cause a halo effect around the particles
about 5 nm in thickness. Therefore, particles within approximately 5 nm of a virus could still
possibly be considered bound to the virus since the NHS functional groups are situated at the end
of the PEG linker.
Figure 19 shows plot profiles for latex beads, PV-1, and HPV-18 before and after
labeling with gold nanoparticles. The latex particles (B) and PV-1 bound numerous AuNPs,
whereas HPV (F) bound none. Profiles were taken using ImageJTM by selecting between 200-300
pixels in length and 20 pixels in width across a given particle.
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Figure 18: AuNP labeling of latex particles, Polio-1 and HPV-18. Forty nm latex beads (A)
labeled with AuNPs (B) were used as controls. C and D show PV-1 before (C) and after (D)
labeling with AuNPs. E and F show HPV-18 before (E) and after (F) labeling with AuNPs. Black
arrows indicate AuNPs. Magnification is 43,000 – 66,000x

52

Figure 19: Intensity plot profiles for 40 nm latex particles (A and B), PV-1 (C and D) and HPV18 (E and F) before (A, C, E) and after (B, D, F) labeling with AuNPs. Grey Value refers to the
average intensity of a set of pixels across the analyzed area represented by the yellow bar. The
bottom axis is the distance in pixels of the analyzed area. Arrows indicate where AuNPs are
located. Insets are the images from where the plot profiles were taken.
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Blocking AuNP Binding to PV-1 with GTA
Figure 20 shows both untreated and GTA-treated PV-1 stained with AuNPs. Treatment of
PV-1 with GTA prevented labeling with AuNPs. Plot profiles confirm the absence of AuNPs on
GTA-treated PV-1. This suggests that GTA treatment disrupts amine-reactive binding sites on
the virus.

Figure 20: Pretreatment of PV-1with GTA blocks AuNP binding. A shows untreated PV-1
labeled with AuNPs. B shows PV-1 (center) that was pretreated with GTA for 1 hour prior to
AuNP labeling. White arrows indicate AuNPs. C and D show plot profiles of 20 x 270 pixel
sections across each inset as in Figure 19.
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Discussion
A comparison of the 6-Log10 reduction estimates for selected Bacillus spores confirms
that not all spores share the same sensitivity to GTA (104, 112). A comparison of two batches of
each spore also shows that kill times can differ slightly, though not significantly, between
batches of spores from the same species created using identical methods, an observation that has
also been seen in other types of organisms with GTA (108). In some cases, the type of
disinfectant used can reverse trends in susceptibility (104).
In addition to the differences seen in susceptibility, the results in Figure 7 also suggest
differentiation of spores into high (B. anthracis), intermediate (B. atrophaues, B. pumilus, and G.
stearothermophilus) and low (B. subtilis) GTA susceptibility. It is has been well-established that
there are vast differences in the kill times of B. anthracis and B. subtilis spores treated with
GTA. Several other studies have shown, using various methods, that G. stearothermophilus, B.
atrophaeus, and B. pumilus have similar kill times to those presented here, though this is the first
time all 5 of these spores have been tested identically and in the same study (86, 115, 137 ). It
should be mentioned that only B. anthracis is clinically relevant. Spores of B. subtilis, B.
atrophaeus, B. pumilus and G stearothermophilus are all generally used as bio-indicators for
sterilization processes (112, 113). Members of the Clostridium genus cause a number of diseases
including Clostridium tetnai (tetanus), C. difficile (pseudomembranous colitis), C. botulinum
(botulism poisoning) and C. pefringens (gas gangrene), but none were tested in this study.
Results of such testing would provide an interesting addition to this data. Previously, GTA has
been tested against all of these spores, though in general, there are fewer studies on disinfection
of Clostridium spores than Bacillus spores (5, 138). This is likely because Clostridium species
are much more difficult to culture, requiring anaerobic environments and producing low spore
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yields (138, 169, 170). It would be interesting to see these same experiments performed on the
more clinically relevant Clostridium spores, in an effort to better determine the effect of species
on spore disinfection.
Figure 8 shows a titration of AF488 with B. anthracis and B. subtilis spores, as well as
the difference in mean fluorescence for each spore type. The elevated mean fluorescence
generated by B. anthracis spores would suggest that they contain more available primary amines,
while B. subtilis likely has fewer. Since it is known that both GTA and AF488 bind to primary
amines, it is likely that increased levels of fluorescence could generally indicate increased
susceptibility to GTA (122, 124-126). The fluorescent profiles in Figure 9 support this idea,
though only somewhat. Since the mean fluorescence of B. subtilis, B atrophaeus and G
stearothermophilus spores were not statistically different from each other, it is likely that up to a
certain threshold, it becomes difficult to predict GTA susceptibility for more resistant spores
using fluorescent amine reactive probes. When mean fluorescence was plotted against 6-Log10
reduction times, there did not seem to be a strict linear relationship between fluorescence and kill
time, although there was a general trend that as fluorescence decreased, kill time increased. More
work needs to be performed on spores with faster kill times (between 4 and 60 minutes) to
determine what that threshold might be. Creating fluorescent profiles for spores from
Clostridium species would also make an interesting addition to these results. Relatively little is
known about Clostridium spore physiology and development. Given Clostridium spores develop
under strict anaerobic conditions, it is conceivable that the structure and or physiology of the
spore is significantly different from that of Bacillus species. This idea is supported by other
studies comparing Clostridium spores to B. subtilis spores (171). In addition, spores from
Bacillus and Clostridium have a number of genetic differences (5, 172).
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Evaluating the ability of GTA to block AF488 binding yielded results that are consistent with
what is known about AF488 and GTA’s binding capabilities (122, 124-126, 153-155). GTA was
able to block fluorescence from AF488 relative to a control, which suggests that AF488 binds to
similar sites used by GTA. This trend was seen even more dramatically with the poliovirus
AuNP labeling experiments discussed later. The residual fluorescence seen in Figure 11 and
Figure 12, after different GTA contact times, may indicate fluorophore that was able to bind
other functional groups such as secondary amines, thiols, phenols, imidazoles, guanidyl and
hydroxyl groups, all of which are likely present on the surface of these spores (167, 173).
Interestingly, we did not see a similar outcome when attempting to block GTA’s
sporicidal action using Alexa FluorTM 647 NHS-ester (AF647). AF647 was used in these
experiments because AF488 contains a primary amine. These experiments, shown in Figure 13
and Figure 14, revealed that GTA could still kill spores pre-stained with fluorophore, with no
associated increase in kill time. There are two possible reasons for this. GTA may have the
ability to kill spores by unknown mechanisms that are not related to primary amine binding. This
is unlikely, given the extensive research that has been done with GTA to determine its preferred
binding sites (23, 116, 142, 174). GTA is also not known to bind DNA or lipids to any degree
that might harm living organisms, let alone spores (33, 127, 132, 133). A more likely alternative
is that GTA has more primary amines available to it than has the fluorophore. Although spore
protein coats are dense, they are permeable to certain small molecules, and have been referred to
as molecular sieves (15, 17, 29). It is conceivable that the spore coat is able to hinder the
movement of the fluorophore (molecular weight = 1250 g/mol) past the outer protein layers,
while GTA (molecular weight = 100.1 g/mol) is able to penetrate faster and deeper into the coat.
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It is important to also note that Gorman suggested that a possible reason for alkaline GTA’s
improved sporicidal activity over acid GTA was due to the ability of the alkalinizing agent,
sodium bicarbonate, to separate layers of the spore coat from each other, giving GTA more
possible targets to bind. It is interesting to note that this separating effect was not observed when
other alkalinizing agents were used (137). Penetration of GTA through empty protein coats of B.
subtilis has also been observed (175).
When the spore protein coat of B. subtilis was removed, there was a marked increase in
its susceptibility to GTA, though again, there was no protection afforded when coatless spores
were stained with AF647 prior to treatment with GTA. This is likely because the peptidoglycan
surrounding the spore’s core can also act as a barrier to large molecular weight compounds, as it
does for vegetative bacteria. Since GTA is known to be able to crosslink peptidoglycan, it is
possible that penetration of GTA beyond the limits of the fluorophore would explain why
pretreatment with AF647 affords no protection, similar to the observations made above with
intact spores (131, 137). Increased susceptibility of de-coated spores to GTA has been observed
previously (10, 11, 168). A repetition of this experiment with the removal of the cortex as well as
the coat, may provide more information on the role these layers play in GTA susceptibility.
Protein coat thickness of the spores used in this study was measured by electron
microscopy. In Figure 16, the differences in spore structure are readily visible. Averages of
measurements taken revealed that B. subtilis had the thickest coat, while B. anthracis and B.
pumilus had the thinnest. G. stearothermophilus and B. atrophaeus had coats about the same
thickness. Although not statistically different from B. atrophaeus and G. stearothermonphilus,
the small difference in thickness between these and B. subtilis, combined with coat composition
differences (i.e., density or number of lysine residues), could account for B. subtilis’s marked
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resistance to GTA. The results shown in Figure 17 suggest a correlation between spore coat
thickness and 6-Log10 reduction estimates for GTA. This agrees with several other studies that
noted that B. subtilis has a much thicker coat than B. anthracis, and suggested that this could be a
contributing factor in B. subtilis’s marked resistance not only to GTA, but many other
disinfectants (10, 16, 18, 50, 176).
Viruses have a much simpler structure than bacterial spores. They are also much smaller
and must be visualized using electron microscopy. Gold particles (AuNPs) which covalently
bind to primary amines were used to visualize these functional groups on the surface of two
viruses; one known to be susceptible to GTA inactivation (poliovirus, or PV-1) and one known
to be resistant (human papillomavirus, or HPV). Although PV-1 was not surrounded by AuNPs
in a manner similar to the latex bead controls (Figure 18), AuNP binding was still considerable.
This was expected since there are likely far fewer primary amine sites on PV-1 than on these
latex beads. Similar results were obtained when labeling adenoviruses with 1.4 nm covalently
linked AuNPs (165). One study investigated the position of lysine groups on protein capsid
secondary structures for various poliovirus-related enteroviruses. They found that the viruses
most resistant to GTA had no lysine groups on secondary structures that were accessible on the
surface of the virus (77). In addition, PV-1 was generally associated with at least 2-3, and often
more AuNPs within 5nm of the virions, which is suggestive that AuNPs are in fact, bound to the
viral capsid. Each AuNP has a 5 kd linker that connects each NHS functional group to its AuNP,
giving the effect of an electron permissive “halo” sometimes visible around the AuNPs.
According to technicians at CytodiagnosticsTM, so long as the particle is within 5 nm of the virus,
it is generally considered bound (personal communication). Profile plots of PV-1 with
associated AuNPs also suggest covalent binding of the particles to the virus (Figure 19). In
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addition, Figure 20 revealed that when PV-1 was treated with GTA prior to labeling with
AuNPs, no such association was observed, and these treated virions appeared similar to HPV-18.
This suggests that GTA is reacting with the binding sites available on the PV-1 capsid surface.
PV-1 has been shown to be susceptible to GTA disinfection, and exposed lysine residues have
been implicated in its susceptibility, as well as the susceptibility of other non-enveloped viruses
(74-76, 107, 135, 140). Since HPV-18 was not observed to be associated with AuNPs, it is
reasonable to conclude that little to no AuNP binding occurred. These results are supported by
our earlier data showing that HPV is not susceptible to GTA inactivation (82). Interestingly,
HPV has been reported to have exposed lysine residues on its capsid surface that are thought to
be important in cell entry, though these residues are located in a pocket that may be protected
somehow from GTA binding. It is also possible that GTA binding simply has no effect on virus
infectivity (177, 178). More research is needed to determine which of these possibilities is
correct. Future experiments should endeavor to explore the ability of covalently linked AuNPs to
block or reduce GTA inactivation of PV-1. Other clinically relevant non-enveloped viruses such
as Hepatitis A, rotaviruses, rhinoviruses, and caliciviruses should be evaluated as well to see if
the trend observed here is consistent with other virus types.
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Conclusions
Caution needs to be exercised when attempting to select an appropriate surrogate for
disinfection testing and when creating decontamination protocols based on data obtained from
surrogate organisms, as kill times can vary greatly between species and even between batches of
the same species. The use of B. subtilis as a surrogate for B. anthracis still seems to be a good
choice when using GTA as the disinfectant, in that B. subtilis spores are much more resistant.
GTA kill for Bacillus species spores is likely influenced by a combination of spore protein coat
thickness and composition. Amine reactive Alexa FluorTM probes could be used as a screening
method when testing novel spores for susceptibility to GTA, although caution should be
exercised since there is not a linear relationship between fluorescence and kill times for Bacillus
spores. The number of available primary amines on viral capsids seems to be related to the
susceptibility of a virus to GTA. For non-enveloped viruses, amine reactive AuNPs could prove
useful for screening novel or fastidious viruses for susceptibility to GTA. These kinds of rapid
preliminary tests could provide valuable susceptibility information that would be useful in
avoiding surrogate-subject discrepancies, as was seen in the failure of GTA to disinfect HPV.
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